A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents

British Journal of Pharmacology

Volumn 125, Issue 2, 1998, Pages 301-308

  Heal, D J ^a   Cheetham, S C ^a   Prow, M R ^a   Martin, K F ^a,b   Buckett, W R ^a  

^a ABBOTT LABORATORIES   (United States)

^b BTG International Ltd   (United Kingdom)

Author keywords

(+) amphetamine; (+) fenfluramine; 5 HT release; 5 HT uptake; BTS 54 354; BTS 54 505; Central 5 HT function; Fluoxetine; Sibutramine

Indexed keywords

1 [1 (4 CHLOROPHENYL)CYCLOBUTYL] 3 METHYL 1 METHYLAMINOBUTANE; 1 AMINO 1 [1 (4 CHLOROPHENYL)CYCLOBUTYL] 3 METHYLBUTANE; 5 HYDROXYTRYPTOPHAN; AMPHETAMINE; ANOREXIGENIC AGENT; FENFLURAMINE; FLUOXETINE; RADIOLIGAND; SEROTONIN; SEROTONIN 2A RECEPTOR; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BINDING AFFINITY; BRAIN SLICE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; FRONTAL CORTEX; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

AMINES; ANIMALS; APPETITE DEPRESSANTS; CYCLOBUTANES; HYPOTHALAMUS, ANTERIOR; MALE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; TRITIUM;

EID: 0031689401     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702067     Document Type: Article

References (48)

1. 3H-mazindol binding in vitro. Life Sci., 43, 651-658.
2. BUCKETT, W.R., THOMAS, P.C. & LUSCOMBE, G.P. (1988). The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog. Neuropsychopharmacol. Biol. Psychiatry, 12, 575-584.
3. CACCIA, S . BIZZI, A., COLTRO, G., FRACASSO, C., FRITTOLI, E., MENNINI, T. & GARATTINI, S. (1992). Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J. Pharm. Pharmacol., 44, 250-254.
4. CARLSSON, A. (1970). Amphetamine and brain catecholamines. In Amphetamine and Related Compounds ed. Costa, E. & Garattini, S. pp. 289-300. New York: Raven Press.
5. 2 receptor binding sites in depressed suicide victims. Brain Res., 443, 272-280.
6. 3H]noradrenaline uptake and effect of DSP-4 and antidepressants treatments. Neuropharmacology, 35, 63-70.
7. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology, 32, 737-743.
8. CLINESCHMIDT, B.V. & BUNTING, P.R. (1980). Differential effects of pharmacological agents acting on monoaminergic systems on drug-induced anorexia. Prog. Neuro-Psychopharmacol., 4, 327-339.
9. FANTINO, M., MARTEL, P., SOUQUET, A.M., WIETESKA, L., BRONDEL, L. & COURCIER, S. (1995). Decrease of food intake and weight loss induced by sibutramine in the rat. Obesity Res., 3, (Suppl 4), S628.
10. FIBIGER, H.C., ZIS, A.P. & MCGEER, E.G. (1973). Feeding and drinking deficits after 6-hydroxydopamine administration in the rat; similarities to the lateral hypothalamic syndrome. Brain Res., 55, 135-148.
11. FULLER, R.W., SNODDY, H.D. & ROBERTSON, D.W. (1988). Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol. Biochem. Behav., 30, 715-721.
12. FULLER, R.W. & WONG, D.T. (1989). Fluoxetine and serotoninergic appetite suppressant drugs. Drug Dev. Res., 17, 1-15.
13. GARATTINI, S., BIZZI, A., CODEGONI, A.M., CACCIA, S. & MENNINI, T. (1992). Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am. J. Clin. Nutr., 55, 1605-1665.
14. GARATTINI, S., MENNINI, T. & SAMANIN, R. (1989). Reduction of food intake by manipulation of central serotonin. Br. J. Psychiatry, 155, 41-51.
15. GOLDSTEIN, D.J., RAMPEY, A.M., GREGORY. G.E., POTVIN, J.H., FLUDZINSKI, L.A. & LEVINE L.R. (1994). Fluoxetine: a randomized clinical trial in the treatment of obesity. Int. J. Obesity, 18: 129-135.
16. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem., 62, 2262-2268.
17. GUNDLAH, C., MARTIN, K.F., HEAL, D.J. & AUERBACH, S.B. (1997). In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J. Pharmacol. Exp. Ther., 283, 581-591.
18. HALFORD, J.C.G., HEAL, D.J. & BLUNDELL, J.E. (1995). Effects in the rat of sibutramine on food intake and the behavioural satiety sequence. Brit. J. Pharmacol., 114, 387P.
19. HEAL, D.J. & CHEETHAM, S.C. (1997). The pharmacology of sibutramine, the first serotonin and noradrenaline reuptake inhibitor to be developed for the treatment of obesity. La Lettre du Pharmacologue, 11, (Suppl. 10), 3-8.
20. HEAL, D., CHEETHAM, S., MARTIN, K., BROWNING, J., LUSCOMBE, G. & BUCKETT, R. (1992a). Comparative pharmacology of dothiepin, its metabolites and other antidepressant drugs. Drug Dev. Res., 27, 121-135.
21. HEAL, D.J. FRANKLAND, A.T.J., GOSDEN, J., HUTCHINS, L.J., PROW, M.R., LUSCOMBE, G.P. & BUCKETT, W.R. (1992b). A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology, 107, 303-309.
22. INVERNIZZI, R., BERETTERA, C., GARATTINI, S. & SAMANIN, R. (1986). D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur. J. Pharmacol., 120, 9-15.
23. JACKSON, H.C., BEARHAM, M.C., HUTCHINS, L.J., MAZURKIEWICZ, S.E., NEEDHAM, A.M. & HEAL, D.J. (1997a). Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol., 121, 1613-1618.
24. JACKSON, H.C. NEEDHAM, A.M., HUTCHINS, L.J. MAZURKIEWICZ, S.E. & HEAL, D.J. (1997b). Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br. J. Pharmacol,. 121, 1758-1762.
25. LOWRY, O.H. ROSEBROUGH, N.J. FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. KELLY, F., JONES, S.P. & LEE, J.K. (1995). Sibutramine: weight loss in depressed patients. Int. J. Obesity, 19, (Suppl.2), P397.
27. KUCZENSKI, R., SEGAL, D.S., CHO, A.K. & MELEGA, W. (1995). Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioural responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci., 15, 1308-1317.
28. MARTIN, K.F., HANNON, S.D., CZUDEK, C., HEAL, D.J. & BUCKETT, W.R. (1995). Comparison of the effects of sibutramine and d-amphetamine on extracellular dopamine levels in rat nucleus accumbens: an in vivo microdialysis study. Br. J. Pharmac., 114, 346P.
29. MUNSON, P.J. & RODBARD, D. (1980). A versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem., 107, 220-239.
30. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
31. PEROUTKA, S.J. & SNYDER, S.H. (1980). Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science, 210, 88-90.
32. RAITERI, M., BONANNO, G. & VALLEBUONA, F. (1995). In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J. Pharmacol. Exp. Ther., 273, 643-649.
33. RICHELSON, E. & PFENNING, M. (1984). Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol., 104, 277-286.
34. RUTTER, J.J. & AUERBACH, S.B. (1993). Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol Exp. Ther., 265, 1319-1324.
35. SAMANIN, R. BENDOTTI, C., BERNASCONI, S., BORRONI, E. & GARATTINI, S. (1977). Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat. Eur. J. Pharmacol., 43: 117-124.
36. SAMANIN, R., BERNASCONI, S. & GARATTINI, S. (1975). The effect of selective lesioning of brain-catecholamine containing neurons of the activity of various anorectics in the rat. Eur. J. Pharmacol., 34: 373-375.
37. SAMANIN, R. & GARATTINI, S. (1982). Neuropharmacology of feeding. In Drugs and Appetite. ed. Silverstone, T. pp. 23-39. London: Academic Press.
38. SCHWARTZ, D., HERNANDEZ, L. & HOEBEL, B.G. (1989). Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res., 482, 261-270.
39. SILVERSTONE, T. & KYRIAKIDES, M. (1982). Clinical pharmacology of appetite. In Drugs and Appetite. ed. Silverstone, T. pp. 93-123. London: Academic Press.
40. STALLONE, D.D., & LEVITSKY, D.A. (1994). Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure. Int. J. Obesity, 18: 679-685.
41. STOCK, M.J. (1997). Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int. J. Obesity. 21, (Suppl.1), S25-S29.
42. STRICKER-KRONGRAD, A., BURLET, C., SOUQUET, A-M. & COURCIER, A. (1995). Sibutramine effects on feeding behaviour: a dose-dependence and microstructural analysis. Obesity Res., 3, (Suppl 4), 631S.
43. STRICKER-KRONGRAD, A., SOUQUET, A-M., JACKSON, H.J. & BURLET, C. (1996). Effect of various monoamine receptor antagonists on the decrease in food intake induced by Sibutramine in the rat. Br. J. Pharmacol., 117, 167P.
44. WESTERINK, B.H.C., TUNTLER, J., DAMSMA, G., ROLLEMA, H. & DE VRIES, J.B. (1987). The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeb. Arch Pharmacol., 336, 502-507.
45. WONG, D.T., BYMASTER, F.P., REID, L.R., FULLER, R.W. & PERRY, K.W. (1985). Inhibition of serotonin uptake by optical isomers of fluoxetine. Drug Dev. Res., 6, 397-403.
46. WONG, D.T., REID, D.L. & THRELKELD, P.G. (1988). Suppression of food intake in rats by fluoxetine; comparison of enantiomers and effects of serotonin antagonists. Pharmacol. Biochem. Behav., 31, 475-479.
47. WORTLEY, K.E., HUGHES, Z.A., HEAL, D.J. & STANFORD, S.C. (1997). Comparison of the effects of Sibutramine and d-amphetamine on the concentration of extracellular noradrenaline in rat frontal cortex: a microdialysis study. Br. J. Pharmacol., 122: 100P.
48. WORTLEY, K.E., HUGHES, Z.A., HEAL, D.J. & STANFORD, S.C. (1998). Effects of RX 821002 on changes in extracellular noradrenaline concentration in rat frontal cortex induced by sibutramine or d-amphetamine. Br. J. Pharmacol. 123: 210P.